BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15623808)

  • 1. Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding.
    Pritts EA; Ryan IP; Mueller MD; Lebovic DI; Shifren JL; Zaloudek CJ; Korn AP; Darney PD; Taylor RN
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2142-7. PubMed ID: 15623808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception.
    Runic R; Schatz F; Krey L; Demopoulos R; Thung S; Wan L; Lockwood CJ
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1983-8. PubMed ID: 9177417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial vasculature in Norplant users.
    Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():45-50. PubMed ID: 8982745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
    Hickey M; Fraser I; Dwarte D; Graham S
    Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
    Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
    Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial angiogenic response in Norplant users.
    Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
    Darney PD; Taylor RN; Klaisle C; Bottles K; Zaloudek C
    Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
    Hickey M; Fraser IS
    Hum Reprod; 2002 Sep; 17(9):2428-34. PubMed ID: 12202436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of vitamin E supplementation to Norplant users--in vitro and in vivo studies.
    Subakir SB; Setiadi E; Affandi B; Pringgoutomo S; Freisleben HJ
    Toxicology; 2000 Aug; 148(2-3):173-8. PubMed ID: 10962136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
    Goodger AM; Rogers PA; Affandi B
    Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of endometrial microvascular basement membrane components in women using Norplant.
    Palmer JA; Lau TM; Hickey M; Simbah M; Rogers PA
    Hum Reprod; 1996 Oct; 11(10):2142-50. PubMed ID: 8943519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium.
    Lau TM; Affandi B; Rogers PA
    Mol Hum Reprod; 1999 Jan; 5(1):57-63. PubMed ID: 10050663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use.
    Kaewrudee S; Taneepanichskul S; Jaisamraun U; Reinprayoon D
    Contraception; 1999 Jul; 60(1):25-30. PubMed ID: 10549449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on relationship between endometrium laminin expression and irregular uterine bleeding in Norplant users].
    Shi X; Han X; Weng J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Mar; 35(3):169-71. PubMed ID: 11775898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The changes of sex steroid receptors and morphology in Norplant treated endometrium].
    Wang G; Zheng S; Fan Z
    Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):493-7. PubMed ID: 10806752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The measurement of endometrial perfusion in norplant users: a pilot study.
    Hickey M; Carati C; Manconi F; Gannon BJ; Dwarte D; Fraser IS
    Hum Reprod; 2000 May; 15(5):1086-91. PubMed ID: 10783358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial biopsy collection from women receiving Norplant.
    Hadisaputra W; Affandi B; Witjaksono J; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():31-4. PubMed ID: 8982743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding.
    Rogers PA; Plunkett D; Affandi B
    Hum Reprod; 2000 Aug; 15 Suppl 3():78-84. PubMed ID: 11041224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.